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Mucosal-associated invariant T cells (MAIT cells) 
are T lymphocytes that express a semi-invariant 
TCR consisting of an “invariant” TCR- chain 
comprised of V19 joined to J33 in mice 
or V7.2 joined to J33 or J12 or J20 in hu-
mans (Reantragoon et al., 2013; Lepore et al., 
2014). These cells express a range of TCR- 
chains, although they are biased toward V6 
and V8 in mice and V2 and V13 in hu-
mans (Le Bourhis et al., 2013; Birkinshaw 
et al., 2014; Ussher et al., 2014). These TCRs 
imbue MAIT cells with the ability to detect 
microbially derived antigens (Ags) presented 
by the monomorphic Ag-presenting molecule 
MHC class I–related protein-1 (MR1) in mam-
mals (Gold et al., 2010, 2014; Le Bourhis et al., 
2010; Reantragoon et al., 2012).
CORRESPONDENCE  
Dale I. Godfrey:  
godfrey@unimelb.edu.au
Abbreviations used: 5-OP-RU, 
5-(2-oxopropylideneamino)-6-
d-ribityl-aminouracil; 6-FP,  
6-formylpterin; Ac-6-FP,  
acetyl-6-FP; Ag, antigen; CBA, 
cytometric bead array; CTV, 
cell trace violet; MAIT cell, 
mucosal-associated invariant  
T cell; PLZF, promyelocytic 
leukemia zinc finger; RORt, 
retinoic acid–related orphan 
receptor t.
*A. Rahimpour and H.F. Koay contributed equally to this 
paper.
Identification of phenotypically and 
functionally heterogeneous mouse  
mucosal-associated invariant T cells  
using MR1 tetramers
Azad Rahimpour,1,2* Hui Fern Koay,1,2* Anselm Enders,3 Rhiannon Clanchy,1 
Sidonia B.G. Eckle,1 Bronwyn Meehan,1 Zhenjun Chen,1 Belinda Whittle,4 
Ligong Liu,5,6 David P. Fairlie,5,6 Chris C. Goodnow,3 James McCluskey,1 
Jamie Rossjohn,7,8,9 Adam P. Uldrich,1,2 Daniel G. Pellicci,1,2  
and Dale I. Godfrey1,2
1Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity and 2Australian Research 
Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Parkville, Victoria 3010, Australia
3Department of Immunology and Infectious Disease and 4Australian Phenomics Facility, John Curtin School of Medical Research, 
Australian National University, Canberra, Australian Capital Territory 2601, Australia
5Institute for Molecular Bioscience and 6Australian Research Council Centre of Excellence in Advanced Molecular Imaging, 
University of Queensland, Brisbane, Queensland 4072, Australia
7Department of Biochemistry and Molecular Biology, School of Biomedical Sciences and 8Australian Research Council Centre 
of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Victoria 3800, Australia
9Institute of Infection and Immunity, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, Wales, UK
Studies on the biology of mucosal-associated invariant T cells (MAIT cells) in mice have 
been hampered by a lack of specific reagents. Using MR1-antigen (Ag) tetramers that 
specifically bind to the MR1-restricted MAIT T cell receptors (TCRs), we demonstrate that 
MAIT cells are detectable in a broad range of tissues in C57BL/6 and BALB/c mice. These 
cells include CD4CD8, CD4CD8+, and CD4+CD8 subsets, and their frequency varies in a 
tissue- and strain-specific manner. Mouse MAIT cells have a CD44hiCD62Llo memory pheno-
type and produce high levels of IL-17A, whereas other cytokines, including IFN-, IL-4,  
IL-10, IL-13, and GM-CSF, are produced at low to moderate levels. Consistent with high  
IL-17A production, most MAIT cells express high levels of retinoic acid–related orphan 
receptor t (RORt), whereas RORtlo MAIT cells predominantly express T-bet and produce 
IFN-. Most MAIT cells express the promyelocytic leukemia zinc finger (PLZF) transcription 
factor, and their development is largely PLZF dependent. These observations contrast with 
previous reports that MAIT cells from V19 TCR transgenic mice are PLZF and express a 
naive CD44lo phenotype. Accordingly, MAIT cells from normal mice more closely resemble 
human MAIT cells than previously appreciated, and this provides the foundation for further 
investigations of these cells in health and disease.
© 2015 Rahimpour et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ 
by-nc-sa/3.0/).
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precursor 5-amino-6-d-ribitylaminouracil (5-A-RU), and 
methylglyoxal or glyoxal, to generate the MAIT cell Ags 
5-(2-oxopropylideneamino)-6-d-ribityl-aminouracil (5-OP- 
RU) nd 5-(2-oxoethylideneamino)-6-d-ribityl-aminouracil 
(5-OE-RU), respectively (Corbett et al., 2014; Rossjohn et al., 
2015). Furthermore, tetramerized human and mouse MR1 
molecules, expressed in soluble form and refolded with the 
5-OP-RU Ag, are capable of detecting all MAIT cells in both 
species (Reantragoon et al., 2013; Corbett et al., 2014).
Before the generation of these MR1 tetramers, the study 
of human MAIT cells has progressed through the use of a 
surrogate staining approach where MAIT cells are typically 
identified as V7.2+CD161+ cells (Martin et al., 2009), and 
indeed, this population was largely coincident with the MR1-
Ag tetramer+ population in humans (Reantragoon et al., 2013). 
Studies of mouse MAIT cells have previously been more diffi-
cult, in part because of the lack of a V19-specific antibody and 
also because of the relative scarcity of these cells (Tilloy et al., 
1999; Treiner et al., 2003). The advent of V19 TCR trans-
genic mice has been a valuable addition to the field, facilitating 
their investigation using mouse models of T cell development 
(Kawachi et al., 2006; Martin et al., 2009; Seach et al., 2013), 
infection (Le Bourhis et al., 2010), and other noninfectious 
diseases (Croxford et al., 2006; Miyazaki et al., 2011). Studies of 
MAIT cells in non-V19 TCR transgenic mice have generally 
relied on polymerase chain reaction to identify the character-
istic V19J33 invariant TCR- chain, sometimes in conjunc-
tion with a surrogate TCR+CD4CD8 phenotype (Tilloy 
et al., 1999; Meierovics et al., 2013). Initial experiments using 
mouse MR1-Ag tetramer demonstrated that MAIT cells 
could be clearly detected in V19 TCR transgenic mice, but 
they have yet to be investigated in non-TCR transgenic mice 
(Reantragoon et al., 2013). Interestingly, some MR1-Ag tet-
ramer+ cells were detected even in V19 TCR Tg mice that 
lacked MR1, suggesting that some of these cells were not 
MR1-restricted MAIT cells (Reantragoon et al., 2013). Fur-
thermore, an unexpected observation from an earlier study 
showed that although human MAIT cells were shown to ex-
press the promyelocytic leukemia zinc finger (PLZF) tran-
scription factor, MAIT cells from V19 TCR transgenic mice 
lacked this factor (Martin et al., 2009). This is in contrast to 
NKT cells, which express PLZF in both species (Kovalovsky 
et al., 2008; Savage et al., 2008). Similarly, MAIT cells in V19 
TCR transgenic mice exhibited a naive CD44-low pheno-
type, whereas human MAIT cells have a memory phenotype 
(Martin et al., 2009). Thus, despite the high level of TCR- 
chain sequence conservation and recognition of common Ags, 
these studies have suggested a fundamental difference in the 
biology of MAIT cells between species. However, given that 
at least some of the MR1 tetramer+ cells that develop in the 
TCR transgenic mice are MR1 independent (Reantragoon 
et al., 2013), it remains to be determined whether these cells 
represent those that develop naturally in non-TCR transgenic 
mice. Thus, the frequency, diversity, subsets, and functional 
characteristics of MAIT cells in normal, nontransgenic mice 
remain unclear.
Recent studies have demonstrated that MAIT cells rec-
ognize riboflavin (vitamin B2) metabolites as a class of MR1-
restricted Ags (Kjer-Nielsen et al., 2012; Patel et al., 2013; 
Corbett et al., 2014; Eckle et al., 2014; McWilliam et al., 2015). 
Riboflavin is produced by many strains of bacteria and yeast, 
and the ability to synthesize riboflavin correlates closely with 
the ability of microbes to induce MAIT cell activation, sug-
gesting that these metabolites are the major class of Ag for 
MAIT cells (Gold et al., 2010; Le Bourhis et al., 2010; Kjer-
Nielsen et al., 2012; Corbett et al., 2014). A recent study 
demonstrated that MR1 presents a nonenzymatically gen-
erated complex derived from the riboflavin biosynthetic 
Figure 1. Identification of MAIT cells using MR1 tetramer in mice. 
(A) Detection of MAIT cells reactive to MR1–5-OP-RU tetramer in human 
and mouse blood. Flow cytometry analysis of human and mouse blood 
showing reactivity to MR1–5-OP-RU tetramer (left) or MR1–Ac-6-FP tetra-
mer (negative control; right). Numbers indicate the percentage of MAIT cells 
(red gate) of total  T cells (black gate). Data are representative of four 
separate experiments with a combined total of n = 6 human blood samples 
and 9 mouse blood samples. (B) Scatter plot depicts MAIT cells as a propor-
tion of T lymphocytes in mouse and human blood, gated as shown in A. Bars 
depict mean ± SEM of n = 6 human blood samples and 9 mouse blood sam-
ples derived from four separate experiments. ***, P < 0.001 using a Mann-
Whitney rank sum U test. (C) B6, V19 C/ transgenic (Tg) MR1+, or 
B6-MR1/ spleen cells were stained with MR1–5-OP-RU tetramer (left 
three plots) or MR1–Ac-6-FP tetramer (far right plot). Numbers indicate the 
percentage of MAIT cells (red gate) of total  T cells (black gate). Data are 
representative of two independent experiments with a combined total of 
four mice. (D) Intensity of TCR- staining on WT and transgenic MAIT cells is 
depicted as histograms, representative of four independent experiments with 
a combined total of six mice. Numbers depict mean fluorescence intensity.
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used for the human cells, and mouse MR1 tetramer was used 
for the mouse cells. These data showed that MAIT cells were 
much less abundant in B6 mouse blood, equating to 0.1% 
of T cells, compared with human blood where they com-
prised 6% of T cells, which falls within the usual range of 
human blood MAIT cells (Fig. 1 A; Le Bourhis et al., 2010; 
Reantragoon et al., 2013). To further investigate the specificity 
of the mouse MR1–5-OP-RU tetramer, we compared spleno-
cytes from WT B6, V19 TCR transgenic.C/ (Kawachi 
et al., 2006), and MR1/ mice (Kawachi et al., 2006). In B6 
mice, there was a clear population of TCRint tetramer+ cells, 
of similar frequency to those in peripheral blood, that was not 
detected with the control MR1–Ac-6-FP tetramer (Fig. 1 C). 
As expected, the MR1–5-OP-RU tetramer also stained an 
abundant population of cells in the TCR transgenic mice, yet 
no population was detected in the MR1/ (Fig. 1 C), thus 
confirming the specificity of mouse MR1–5-OP-RU tetramer 
for MAIT cells. Staining of MR1/ mouse cells with MR1–
Ac-6-FP tetramer also failed to show a population of tetra-
mer+ cells, as expected (not depicted). To formally establish 
that the population of MR1–5-OP-RU tetramer+ TCRint 
cells were indeed MAIT cells, single cells were sorted and TCRs 
In this study, we have undertaken an MR1 tetramer–based 
investigation of mouse MAIT cells from normal mice, includ-
ing analysis of subsets defined by CD4 and CD8, cytokine 
production, and transcription factor expression. These studies 
have revealed previously unrecognized characteristics of mouse 
MAIT cells, including a constitutive memory phenotype; the 
existence of a major population of IL-17–producing, retinoic 
acid–related orphan receptor t (RORt)+ and a minor pop-
ulation of IFN-–producing, T-bet+ MAIT cells; and high levels 
of PLZF expression and dependence on this transcription fac-
tor for MAIT cell development.
RESULTS
Identification of MAIT cells in WT mice
Using 5-OP-RU–loaded MR1 tetramers, MAIT cells can be 
readily identified in human peripheral blood and in V19 
TCR transgenic mice (Reantragoon et al., 2013; Corbett et al., 
2014). To directly compare human and mouse MAIT cells, 
we labeled peripheral blood lymphocytes from both species 
with either MR1–5-OP-RU (Corbett et al., 2014) or control 
nonantigenic MR1–acetyl-6-formylpterin (6-FP [Ac-6-FP]) 
tetramers (Eckle et al., 2014). Human MR1 tetramer was 
Table 1. TCR sequences of MR1–5-OP-RU tetramer+ TCR intermediate cells
Seq TRAV TRAJ CDR3 TRBV TRBJ CDR3
1 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-7 CASGDGDWGREQYF
2 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-3 CASSRXGGXSAETLYF
3 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-5 CASSDGTXQDTQYF
4 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ1-3 CASSGTSSGNTLYF
5 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-3 CASGGGDSAETLYF
6 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-3 CASSDTGGAQETLYF
7 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV1 TRBJ2-4 CTCSGDSQNTLYF
8 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-7 CASGVGDYEQYF
9 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-7 CASGDGGAPSYEQYF
10 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-3 CASGDDWGGRAETLYF
11 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-5 CASGLGGRQDTQYF
12 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-7 CASSAGTSSYEQYF
13 TRAV1 TRAJ33 CAVMDSNYQLIW TRBV13-2 TRBJ2-3 CASGGDGDSAETLYF
14 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-1 CASSKGDYAEQFF
15 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-3 CASGEETGGAETLYF
16 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ1-2 CASSGTTNSDYTF
17 a) TRAV1 
b) TRAV6-4a
TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-5 CASGLGGRQDTQYF
18 a) TRAV1 
b) TRAV6-5a
TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-3 CASGDADRGQGAETLYF
19 a) TRAV1 
b) TRAV3-3a
TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-4 CASSDAASQNTLYF
20 a) TRAV1 
b) TRAV9Na
TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-1 CASGDGDSYAEQFF
21 a) TRAV1 
b) TRAV12a
TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBV2-7 CXSGDGGAPSYEQYF
MR1–5-OP-RU tetramer+ TCR- intermediate cells from B6 mouse spleen, gated in a similar manner to that shown in Fig. 1 C, were sorted as single cells, and TCR- and - 
chains were sequenced. Data are derived from two independent experiments with spleens from two mice per experiment. X, sequence unclear.
aMixed unproductive sequences.
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Tissue distribution of mouse MAIT cells
Having identified MAIT cells in blood from WT mice, we 
next examined these cells in other tissues of two commonly 
used mouse strains (B6 and BALB/c), including thymus, 
spleen, liver, lymph node (inguinal), lung, and lamina propria 
(Fig. 2, A and B). Negative controls included MR1–Ac-6-FP 
tetramer (Fig. 2 A) and MR1–5-OP-RU tetramer staining 
of tissues from MR1/ mice (similar to Fig. 1 C and not 
depicted). The data indicate the percentage of MAIT cells 
of total TCR+ cells. MAIT cells were difficult to detect 
in whole mouse thymus (<0.1%), but after complement- 
mediated depletion of immature thymocytes using anti-CD24, 
a clear population of MAIT cells was observed, represent-
ing 0.3% of mature (CD24 depleted) TCR+ thymocytes. 
MAIT cells were identified in all other tissues, although their 
frequency varied considerably. In B6 mice, the highest per-
centage was detected in lung (mean 3.3%), followed by lamina 
propria (mean 0.7%), liver (mean 0.6%), peripheral lymph 
nodes (mean 0.2%), spleen (mean 0.08%), and thymus (mean 
0.05%; Fig. 2 B). In BALB/c mice, MAIT cells were generally 
less frequent as a percentage of total TCR+ cells, although 
sequenced after PCR amplification (Table 1). As expected, of 
the 21 cells where matched TCR- and TCR- chains were 
successfully identified, all expressed the MAIT cell invariant 
TRAV1-TRAJ33 (V19-J33) TCR- chain, paired with 
a range of TCR- chains that were highly enriched for 
TRBV13-3 and TRBV13-2 (V8.1 or V8.2), consistent with 
the previously documented MAIT TCR- bias (Tilloy et al., 
1999; Reantragoon et al., 2013; Lepore et al., 2014). In contrast 
to human MAIT cells, which can also use J12 and J20 instead 
of J33 (Reantragoon et al., 2013; Gold et al., 2014; Lepore et al., 
2014), no alternate J gene usage was observed within the 21 
productive TCR- sequences derived from these experiments, 
suggesting that mouse MAIT cells have a strong dependence on 
this TCR element. Similar to NKT cells, MAIT cells expressed 
lower levels of TCR compared with conventional T cells, and 
furthermore, their TCR levels were also almost twofold lower 
in normal mice compared with V19 TCR transgenic C/ 
mice (Fig. 1 D), which may reflect transgenic overexpression 
of the TCR in these mice. Accordingly, MR1–5-OP-RU 
tetramers can be used to specifically detect MAIT cells in 
WT mice.
Figure 2. Tissue distribution of MAIT cells.  
(A) Flow cytometry analysis of naive mouse thymus, 
enriched thymus, spleen, lymph nodes (inguinal), 
liver, lung, and lamina propria, showing reactivity to 
MR1–5-OP-RU tetramer or MR1–Ac-6-FP tetramer. 
Plots depict lymphocytes with B220+ B cells excluded 
by electronic gating. B6 mice are depicted in the top 
group and BALB/c in the bottom group. Numbers 
indicate the percentage of MAIT cells (red gate) of 
total  T cells (black gate). (B) Scatter plots depict 
MAIT cells as a proportion of T lymphocytes in all 
tissues tested, gated as shown in A. Each symbol 
represents an individual mouse. Bars depict mean ± 
SEM, and data are derived from a minimum of three 
independent experiments for each strain, with a com-
bined total of 6–12 mice per tissue.
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Figure 3. Phenotypic diversity within mouse MAIT cells. (A) Flow cytometry analysis of CD4 and CD8 coreceptor expression on MAIT cells from thy-
mus, spleen, lymph nodes (inguinal), liver, and lung from B6 mice. (B) CD4/CD8 coreceptor–defined subsets of MAIT cells as a proportion of total MAIT 
cells in each tissue, gated as shown in A. Each symbol represents an individual mouse. Bar graphs depict mean ± SEM. Data are derived from a minimum 
of three independent experiments for each strain, with a combined total of 6–10 mice per tissue. (C) Phenotypic analysis of MAIT cells (thick black lines) 
from thymus, spleen, and lung compared with other (MR1–5-OP-RU tetramer TCR-+) T cells (shaded gray) depicted as histograms. Histograms for each 
marker, apart from CD218, show data concatenated from three separate mouse tissue samples from within one experiment and are representative of 
three similar experiments. Histograms for CD218 are representative of two experiments with four mice per experiment. (D) CD3+ and 5-OP-RU–reactive 
cells were stained for a panel of V antibodies, and positive cells were plotted as a proportion of total MAIT cells. Bar graphs depict mean ± SEM from 
three independent experiments, each involving a pool of 10 mice.
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a similar distribution was observed. In this strain, the liver 
housed the highest frequency of MAIT cells (mean 0.4%), 
followed by lung (mean 0.2%), spleen (mean 0.04%), thymus 
(mean 0.02%), and lymph nodes (mean 0.01%; Fig. 2, A and B). 
BALB/c lamina propria was not tested. In BALB/c thymus, 
MAIT cells were only clearly detectable after depletion of 
immature thymocytes with anti-CD24 antibody (Fig. 2 A). 
We were unable to detect a clear population of MAIT cells 
within the intraepithelial compartment of the gastrointestinal 
tract (not depicted). Thus, in mice, MAIT cells appear to be 
distributed in the same tissues as conventional T cells, although 
their relative frequency appears to be differentially regulated 
compared with control conventional T cells.
Cell surface phenotype heterogeneity of mouse MAIT cells
To investigate MAIT cell subsets and examine the activation 
and differentiation state of mouse MAIT cells, we colabeled 
MR1–5-OP-RU tetramer+ MAIT cells from B6 and BALB/c 
strains with antibodies specific for CD4 and CD8 (Fig. 3, 
A and B). In all tissues tested from B6 mice, the majority of 
MAIT cells were CD4CD8, although CD4+ and CD8+ 
subsets were also detected in lower proportions and with varied 
frequencies in a tissue-specific manner. For example, very 
few CD8+ MAIT cells (<5%) were detected in lymph nodes, 
whereas CD4+ MAIT cells were abundant (40%) in this tis-
sue (Fig. 3, A and B), whereas CD4+ MAIT cells were virtually 
undetectable in lung. Furthermore, the expression level of CD4 
and CD8 on MAIT cells were typically lower than on conven-
tional T cells (Fig. 3 A and not depicted). CD8+ MAIT cells 
in mice included a mix of both CD8+ and CD8++ cells 
at roughly equal ratios, similar to human CD8+ MAIT cells (not 
depicted; Martin et al., 2009; Walker et al., 2012; Reantragoon 
et al., 2013). BALB/c MAIT cells also included the same three 
subsets based on CD4 and CD8 expression, although in this 
strain there were more CD8+ MAIT cells in thymus and a sim-
ilar ratio of double-negative and CD8+ MAIT cells in spleen, 
lymph node, and liver (Fig. 3 B). Interestingly, similar to B6 
mice, CD4+ MAIT cells were abundant (55%) in lymph nodes 
from BALB/c mice, suggesting that CD4+ MAIT cells pref-
erentially reside in these organs.
We also examined other cell surface markers on MAIT cells 
from B6 mice, including activation and differentiation mark-
ers and chemokine and cytokine receptors: CD44, CD69, 
CD103, CD62L, CD127 (IL-7R), CD161 (NK1.1), CCR9, 
CXCR6, and CD218 (IL-18R; Fig. 3 C). MAIT cells were 
uniformly high for CD44 and low for CD62L expression, 
reflecting a memory phenotype, which contrasts with earlier 
studies of V19 TCR transgenic.C/ MAIT cells, which 
were described as naive CD44lo cells (Kawachi et al., 2006; 
Martin et al., 2009). In contrast to NKT cells, which express 
CD69 (Godfrey et al., 2010), most MAIT cells were CD69lo, 
suggesting that they are not constitutively activated in mice. 
NK1.1 (CD161) was expressed by a subset (30–50%) of 
MAIT cells in thymus and spleen, whereas lung MAIT cells 
were negative for this marker. This contrasts with human 
MAIT cells, which are almost entirely CD161hi (Martin et al., 
2009; Reantragoon et al., 2013). CD103, a mucosal homing 
receptor, showed bimodal expression on MAIT cells in each 
tissue tested, consistent with their ability to migrate to muco-
sal tissues. CD127 and CD218 were both expressed by the 
majority of MAIT cells, in line with the expression of these 
markers on human MAIT cells (Tang et al., 2013; Leeansyah 
et al., 2014). Of the chemokine receptors tested, MAIT cells 
were uniformly high for CXCR6 (similar to NKT cells 
[Geissmann et al., 2005]) and a subset expressed CCR9 (Fig. 3 C), 
but they were not observed to express other chemokine re-
ceptors including CCR4, CCR7, CXCR3, CX3CR1, and 
CXCR4 (not depicted). As CCR9 and CXCR6 are associated 
with homing to nonlymphoid tissue and mucosal tissue, this is 
consistent with the observed distribution of MAIT cells in mice.
Next we examined TCR V usage by MAIT cells from 
B6 mice in different tissue compartments to determine whether 
the V8 bias was consistent in all tissues. This was achieved by 
costaining with MR1-Ag tetramer and anti-V–specific anti-
bodies (Fig. 3 D). These data revealed that, consistent with 
the TCR sequencing data (Table 1) and as previously pub-
lished (Tilloy et al., 1999; Kawachi et al., 2006; Reantragoon 
et al., 2013), a major population (55%) of MAIT cells use 
V8.1/V8.2 genes and a moderate bias toward the use of 
V6 (15%), albeit less than was expected based on the orig-
inal study of mouse MAIT cells (Tilloy et al., 1999). This may 
be simply caused by differences resulting from the use of 
T cell hybridomas for V analysis in the earlier study (Tilloy 
et al., 1999), compared with freshly isolated MAIT cells here. 
Furthermore, we detected expression of a range of V genes, 
including V2, 3, 4, 5, 6, 7, 8.3, 9, 10, and 14, at low but detect-
able frequency. Moreover, similar V distributions were ob-
served for MAIT cells isolated from thymus, spleen, and lung, 
suggesting that recruitment to different tissues is not influenced 
by TCR- chain repertoire.
PLZF expression by mouse MAIT cells
The transcription factor PLZF is considered to be a master 
regulator of innate-like T cells, including NKT cells (Kovalovsky 
et al., 2008; Savage et al., 2008) and  T cells (Kreslavsky et al., 
2009). We examined PLZF expression in mouse MAIT cells 
from spleens of B6 WT and V19 TCR transgenic.C/ mice 
(Fig. 4 A). Whereas the WT MAIT cells were almost all PLZFhi, 
most of the TCR transgenic MAIT cells from spleen were 
PLZFlo, which is reminiscent of a previous study suggesting 
that V19 TCR transgenic.C/ MAIT cells lacked this tran-
scription factor (Martin et al., 2009). Interestingly, the percent-
age of V19 TCR transgenic MAIT cells that were PLZFhi was 
higher in lung (mean 61%) compared with spleen (mean 33%; 
Fig. 4 B). Nearly all (>95%) of the PLZFhi MAIT cells also ex-
pressed high levels of the memory T cell marker CD44, regard-
less of whether they were from WT or V19 TCR transgenic 
mice, whereas many but not all of the PLZFlo MAIT cells that 
were abundant in the TCR transgenic mice also lacked CD44 
expression (Fig. 4, A and B).
Given the high expression of PLZF by mouse MAIT cells, 
this raised the question of whether the development of these 
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factor PLZF and, furthermore, that the development of 
these cells is highly, although not absolutely, dependent on 
PLZF expression.
Most mouse MAIT cells produce IL-17A and express RORt
Previous studies of V19 TCR transgenic mice have suggested 
that, similar to NKT cells, mouse MAIT cells can produce 
high levels of a range of cytokines including IL-4, IL-5, IL-10, 
IFN-, and TNF (Kawachi et al., 2006). Here, we stimulated 
MAIT cells from thymus, lung, and spleen of WT mice using 
PMA and ionomycin for 4 h and measured acute cytokine 
production by intracellular cytokine staining (Fig. 5 A and not 
depicted). These data suggested that very few MAIT cells were 
able to produce IFN- (Fig. 5 A) and IL-4 (not depicted). In 
contrast, the majority of NKT cells in the same experiments 
were clearly capable of producing both IFN- (Fig. 5 A) and 
IL-4 (not depicted). However, the majority of MAIT cells from 
the thymus, spleen, and lung were able to produce very high 
levels of the proinflammatory cytokine IL-17A, whereas 
cells was dependent on this transcription factor, which is 
known to control the development of NKT cells (Kovalovsky 
et al., 2008; Savage et al., 2008). To directly test this, we exam-
ined MAIT cells in mice with a T to A transversion in exon 2 
of the Plzf gene that changes a tyrosine to a premature stop 
codon (Y70Stop; not depicted; PLZFnull mice). MAIT cells 
were almost completely absent in thymus, spleen, and lymph 
nodes of these mice, although a residual population (<10% 
of the number in WT B6 mice) remained (Fig. 4, C and D). 
Single cell TCR sequencing of these residual cells revealed 
that they expressed the invariant TRAV1-TRAJ33 (V19-
J33) TCR- chain and were enriched for TRBV13-3 and 
TRBV13-2 (V8.1 or V8.2; Table 2), supporting the con-
cept that they were indeed MAIT cells. Interestingly, these 
residual MAIT cells were enriched for the CD4+ MAIT cell 
subset (not depicted), suggesting that at least some CD4+ 
MAIT cells may be developmentally distinct to CD4 MAIT 
cells. Accordingly, these experiments indicated that, like 
NKT cells, MAIT cells express high levels of the transcription 
Figure 4. MAIT cells express PLZF and 
are PLZF dependent. (A) MAIT cells from WT 
B6 mice (top row) and V19 TCR Tg C/ 
mice (bottom row). Plots in first column de-
pict lymphocytes with B220+ B cells excluded 
by electronic gating. Numbers indicate the 
percentage of MAIT cells (red gate) of total 
 T cells (black gate). MAIT cells and non-
MAIT “T cells,” gated as shown in the first 
column, were examined for PLZF versus TCR-  
(second and third columns) and PLZF versus 
CD44 (fourth and fifth columns) expression. 
Data are representative of four separate ex-
periments with a combined total of six mice 
per group. (B) Scatter plots depict the per-
centage of PLZF+ and CD44+ MAIT cells from 
spleen and lung of WT and V19 TCR trans-
genic C/ mice. Each symbol represents an 
individual mouse. Bars depict mean ± SEM 
from a total of six separate mice. (C) Presence 
of MAIT cells in thymus, spleen, and lymph 
nodes of B6 WT and PLZFnull mice. Plots depict 
lymphocytes with B220+ B cells excluded by 
electronic gating. Top row shows PLZFnull 
mice, and bottom row shows WT mice. Num-
bers indicate the percentage of MAIT cells (red 
gate) of total  T cells (black gate). Data are 
representative of three independent experi-
ments with a combined total of six to seven 
mice per group. (D) Percentage (top row) and 
total numbers (bottom row) of MAIT and  
NKT cells (CD1d–-GalCer tetramer+ T cells) 
of total lymphocytes in thymus, spleen, and 
lymph nodes. Each symbol represents a differ-
ent mouse. Bars depict mean ± SEM. For  
C and D, data are representative of three inde-
pendent experiments with a combined total  
of six to seven mice per group. **, P < 0.01; 
***, P < 0.001; ****, P < 0.0001 using a Mann–
Whitney rank sum U test.
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appeared to be mutually exclusive (Fig. 6 A). In contrast, most 
NKT cells expressed T-bet and only a small subset expressed 
RORt, whereas conventional T cells mostly lacked these 
transcription factors (Fig. 6 A). To directly test whether these 
transcription factors are associated with the cytokine profile of 
mouse MAIT cells, we investigated cytokine production 
by RORt+ and T-bet+ MAIT cells isolated from thymus. 
These data indicated that the rare IFN-+ MAIT cells were 
T-bet+RORtlo, whereas IL-17A was exclusively produced 
by the RORthi MAIT cells. Although some of the IL-17A+ 
MAIT cells also appeared to express low levels of T-bet 
(Fig. 6 B), we noted that T-bet expression moderately in-
creased on MAIT cells upon stimulation (Fig. 6 B). Thus, it 
is likely that the IL-17A+RORthi MAIT cells were derived 
from the predominant T-bet MAIT cell population, whereas 
IFN- was produced by the T-bet+RORtlo MAIT cells 
(Fig. 6 B). Collectively, these results suggested the existence 
of two functionally distinct populations of MAIT cells, gov-
erned by differential transcription factor expression in mice.
Mouse MAIT cells respond to Ag-mediated stimulation
To determine whether WT mouse MAIT cells can respond 
directly to challenge with the 5-OP-RU Ag, B6 mouse spleno-
cytes were cultured in the presence of graded doses of this Ag 
for 3 d, and MAIT cell proliferation was measured by dilution 
of the cell trace violet (CTV) fluorescent dye (Fig. 7, A and B). 
These data show that mouse MAIT cells responded in a dose-
dependent manner (Fig. 7, B and C) to the 5-OP-RU Ag, 
expression of this cytokine was limited to a small subset of 
NKT cells from the same organs (Fig. 5 A). We also examined 
production of these cytokines by MAIT cell subsets defined 
by CD4/CD8 expression but did not observe any clear differ-
ences (not depicted). To investigate cytokine production in 
response to TCR ligation, we next isolated MAIT cells from 
thymus, spleen, and lung and stimulated them in vitro with 
plate-bound CD3 and CD28 antibodies, measured cytokine 
secretion into the culture supernatant after 24 h (Fig. 5 B and 
not depicted), and compared them with NKT cells and con-
ventional T cells. This confirmed that thymic MAIT cells are 
capable of producing a broad range of cytokines including 
IL-4, IL-10, IL-13, GM-CSF, IFN-, and TNF, although gen-
erally at low levels (<100 pg/ml). In line with the intracellular 
cytokine staining data, IL-17A was produced at extremely high 
levels by thymic MAIT cells, at least 10-fold higher than that 
of NKT cells and conventional T cells in the same experiments 
(Fig. 5 B). Generally lower levels of cytokines were detected 
from spleen (Fig. 5 B) and lung MAIT cells (not depicted) 
although IL-17A was the main cytokine produced by these 
cells in these assays.
Given that MAIT cells express high levels of IL-17A and 
low levels of IFN-, we next examined the transcription fac-
tors RORt and T-bet, which in other cell types including 
NKT cells are associated with production of these cytokines, 
respectively (Lee et al., 2013). These results showed that most 
MAIT cells expressed RORt, whereas only a small subset 
(5–30%) expressed T-bet, and these transcription factors 
Table 2. TCR sequences of MR1–5-OP-RU tetramer+ cells in PLZF KO mice
Seq TRAV TRAJ CDR3 TRBV TRBJ CDR3
1 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-1 CASGDAEDYAEQFF
2 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-4 CASSDRGXGSQNTLYF
3 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-7 CASGDAEDYAEQFF
4 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV19 TRBJ2-7 CASSIGDTYEQYF
5 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV19 TRBJ2 CASSPTGGEGYAEQFF
6 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ1-2 CASGDGDSYAEQFF
7 a) TRAV1 
b) TRAV6a
TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-2 CASSEGRDTGQLYF
8 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV14 TRBJ2-7 CASSFDIYEQYF
9 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-1 CASSGTVYAEQFF
10 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-1 CASGGTYYAEQFF
11 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-7 CASTGTGISYEQYF
12 TRAV1 TRAJ33 CAVRDSNYQLIW ND
13 TRAV1 TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-4 CASXXXGGASQNTLYF
14 a) TRAV1 
b) TRAV5Da
TRAJ33 CAVRDSNYQLIW TRBV13-3 TRBJ2-5 CASSDRGQDTQYF
15 a) TRAV1 
b) TRAV10a
TRAJ33 CAVRDSNYQLIW TRBV13-2 TRBJ2-1 CASGDGGAPSYEQYF
16 a) TRAV1 
b) TRAV10a
TRAJ33 CAVRDSNYQLIW TRBV1 TRBJ2-4 CTCSAVWFSQNTLYF
MR1–5-OP-RU tetramer+ TCR intermediate cells from PLZFnull mouse spleen, gated in a similar manner to that shown in Fig. 4 C, were sorted as single cells, and TCR- and - 
chains were sequenced. Cells were derived from spleens from two mice per group. X, sequence unclear.
aMixed unproductive sequences.
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Figure 5. Cytokine production by MAIT cells. (A) CD24-depleted mouse thymocytes were stimulated for 4 h in PMA/ionomycin, after which time the 
cells were labeled with MR1-Ag tetramer and then fixed and permeabilized before staining with anti–IFN- or IL-17A. Data are representative of three experi-
ments with a combined total of six mice per group. (B) MAIT cells, NKT cells (CD1d–-GalCer tetramer+ T cells), and conventional MR1 tetramer TCR-+ T cells 
were sorted from WT spleen and thymus and then added at 10,000 cells/well and stimulated by plate-bound CD3 and CD28. Supernatants were harvested  
at 24 h, and cytokines were analyzed by CBA. Graphs depict the mean concentration of cytokines ± SEM from three independent experiments for thymus  
and spleen, each using MAIT cells pooled from 10 mice. Dashed lines are the cutoff at 10 pg/ml for clearly detectable cytokine production.
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production of IL-17A in response to Ag, albeit at lower levels 
than that seen after CD3 and CD28 stimulation (not de-
picted). Accordingly, these data demonstrate that WT mouse 
MAIT cells can recognize and respond specifically to the ago-
nist ligand, 5-OP-RU in a dose-dependent manner.
DISCUSSION
MR1-restricted, riboflavin metabolite–reactive, MAIT cells 
are a unique T cell lineage that is present in mice and humans 
and other mammals (Le Bourhis et al., 2013; Birkinshaw et al., 
2014; Ussher et al., 2014). Despite their discovery 15 years ago 
(Tilloy et al., 1999), the biology of these cells remains poorly 
defined, in part because of difficulties in identifying them 
in mice, thereby limiting the study of MAIT cell function 
in mouse models of development and disease. Some studies have 
used V19 TCR transgenic C/ mice (Okamoto et al., 
2005; Kawachi et al., 2006; Martin et al., 2009), although how 
these compare with MAIT cells in WT mice was unclear. Our 
experiments on MAIT cells, using MR1–5-OP-RU tetramer 
in WT mice including two commonly used strains (B6 and 
BALB/c), revealed that these cells are relatively rare compared 
with MAIT cells in humans, although they clearly are present 
in all tissues where T cells are detected.
In this study, we have demonstrated the existence of mul-
tiple subsets of mouse MAIT cells defined by CD4/CD8 ex-
pression, differential expression of the transcription factors 
RORt and T-bet, and an associated differential production 
of the cytokines IL-17A and IFN-, respectively. Although 
our studies of cytokine production were partly in agreement 
with a previous study with rapid production of a range of 
cytokines (Kawachi et al., 2006), we observed that the most 
prominent cytokine produced by these cells was IL-17A, a 
proinflammatory cytokine that has previously been identified 
as a product of human MAIT cells (Dusseaux et al., 2011; 
Walker et al., 2012; Tang et al., 2013). Furthermore, IL-17A–
producing MAIT cells are prominent in psoriatic skin lesions 
in humans (Teunissen et al., 2014), suggesting an important 
role for these cells in this disease. Indeed, mouse MAIT cells 
produced far higher levels of IL-17A than NKT cells and 
conventional T cells in parallel cultures, and the majority of 
MAIT cells produced this factor. Consistent with the high 
IL-17A production, most mouse MAIT cells expressed high 
levels of the transcription factor RORt, and it was these 
MAIT cells that produced IL-17A, whereas a smaller subset of 
the mouse MAIT cells that were RORtlo instead expressed 
T-bet. The latter population was responsible for the production 
of IFN- and notably did not coexpress IL-17A. Given that 
these two populations were both detected in thymus, these 
data are reminiscent of a recent study that shows multiple de-
velopmentally distinct subsets of NKT cells that are thought 
to develop as separate lineages during intrathymic develop-
ment (Lee et al., 2013). Accordingly, these data highlight the 
existence of at least two functionally distinct subpopulations of 
mouse MAIT cells: a major RORt+T-betlo IL-17A–producing 
subset and a minor RORtloT-bet+ IFN-–producing subset. 
whereas they did not respond to the control MR1-binding 
nonagonist 6-FP (Fig. 7, A and B). Cytokines, including IFN-, 
were also detected in these cultures (not depicted), although 
the amounts were lower and more variable than in cultures of 
purified MAIT cells (Fig. 5), likely because of the low fre-
quency of MAIT cells in the bulk culture. When MAIT cells 
were purified by flow cytometric sorting of MR1–5-OP-RU 
tetramer+TCR-+ cells and stimulated with 5-OP-RU Ag in 
the presence of MR1+ Ag-presenting cells, we detected clear 
Figure 6. Most MAIT cells are RORthi and produce IL-17A.  
(A) MAIT cells, NKT cells (CD1d–-GalCer tetramer+), and conventional TCR-+ 
T cells were labeled with antibodies specific for RORt and T-bet. (B) Samples 
from thymus, spleen, and lung were stimulated for 4 h in vitro with PMA/
ionomycin, and expression of RORt and T-bet and production of IFN- 
and IL-17A by MAIT and NKT cells were analyzed by flow cytometry. Data 
are representative of four experiments, with a combined total of eight mice.
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cytokine receptors, including CD127 (IL7R) and CD218 
(IL18R), and chemokine receptors (CCR9 and CXCR6; 
Dusseaux et al., 2011). A striking difference between MAIT cells 
in mice and humans is their frequency within the T cell pop-
ulation. Although in humans MAIT cells are highly abundant, 
representing up to 10% of T cells in blood (Le Bourhis et al., 
2010) and up to 45% of T cells in liver (Dusseaux et al., 2011), 
in mice MAIT cells are far less abundant in all tissues tested, 
including liver, rarely representing more than 1% of T lym-
phocytes. Given the known role for microbial stimulation in 
MAIT cell expansion (Treiner et al., 2003), and the fact that 
MAIT cells are less abundant in human thymus and cord blood 
(Martin et al., 2009), it is tempting to speculate that one rea-
son for the differences in MAIT cell numbers between labo-
ratory mice and humans is that humans are far more likely to 
suffer from microbial infections than laboratory mice from 
clean animal facilities.
The expression of high levels of PLZF by the vast major-
ity of MAIT cells was consistent with the concept that these 
cells undergo a similar developmental programming to other 
“innate-like” T cells, including NKT cells,  T cells, and 
other, as-yet-undefined, innate-like T cells, that also express 
this transcription factor (Kovalovsky et al., 2008; Savage et al., 
2008; Kreslavsky et al., 2009; Prince et al., 2014). This is not 
unexpected because positive selection of MAIT cells requires 
an interaction with MR1 expressed by CD4+CD8+ double-
positive thymocytes (Seach et al., 2013), and this is a SAP- 
dependent process (Martin et al., 2009). These factors appear 
to initiate the alternate developmental pathway that results in 
the potent cytokine-producing, CD44hi memory phenotype 
(Godfrey et al., 2010), which is shared by MAIT and NKT cells. 
Indeed, our observation that MAIT cells are almost entirely 
It will be important to examine these subsets separately in 
future studies of MAIT cell biology.
We have detected some important differences between 
MAIT cells in WT mice and those that develop in V19 TCR 
transgenic.C/ mice. In the TCR transgenic mice, MAIT 
cells were previously reported as having a naive CD44lo phe-
notype and lacking the transcription factor PLZF (Martin 
et al., 2009). Here, using MR1–5-OP-RU tetramer we also 
observed that many, though not all, MAIT cells in TCR trans-
genic mice were CD44loPLZFlo. In contrast, nearly all of 
the MAIT cells detected in WT mice exhibited a memory 
CD44hi, CD62Llo phenotype and were PLZFhi. This indicates 
that MAIT cells in WT mice are more comparable with human 
MAIT cells than was previously realized because human 
MAIT cells also exhibit a memory phenotype and are PLZF+ 
(Martin et al., 2009). It is not clear why MAIT cells in WT mice 
are so different from the V19 TCR transgenic.C/ mice, 
but it may be that aberrant timing or expression levels of the 
TCR transgene, or the absence of T cells expressing other 
TCR- chains in the C/ background, disrupts the normal 
MAIT cell developmental pathway. Regardless, these findings 
suggest that some aspects of MAIT cell development and 
function in a TCR transgenic background may not reflect 
MAIT cell biology in normal mice and humans.
There are many similarities between MAIT cells in WT 
mice and humans. As previously established, they express 
orthologous TRAV1-TRAJ33 TCR- chains (Tilloy et al., 
1999), and as confirmed here, they recognize the same ribo-
flavin metabolite–based Ag (5-OP-RU) presented by MR1, 
and they include CD4+, CD4CD8, and CD8+ subsets. 
Furthermore, both mouse and human MAIT cells express 
PLZF, they produce high levels of IL-17A, and they share 
Figure 7. MAIT cells proliferate upon Ag stimu-
lation in vitro. Splenocytes were labeled with CTV 
and cultured in the presence of 5-OP-RU, 6-FP, or no 
Ag. After 72 h, MAIT cell numbers and CTV dilution 
were measured by flow cytometry. (A) Left column 
shows representative flow cytometry profiles show-
ing percentage of MAIT cells (MR1–5-OP-RU-tetramer+) 
of total T cells. Plots depict lymphocytes with B220+ 
B cells excluded by electronic gating. Right column 
shows MAIT cell and T cell proliferation based on 
decreased CTV dye dilution. Black histograms, MAIT 
cells; gray histograms, MR1 tetramer T cells. Data 
are representative of a minimum of two separate 
experiments with a combined total of four mice.  
(B) Bar graph depicts percentage of expanded  
MAIT cells, gated as shown in A (mean ± SEM) from 
two independent experiments and a combined total 
of four mice. (C) Representative flow cytometry pro-
files showing CTV dilution of MAIT cells at each Ag dose. 
Data are representative of a minimum of two sepa-
rate experiments with a combined total of four mice. 
Black histograms, MAIT cells; gray histograms, MR1 
tetramer T cells.
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37°C on a shaker (200 rpm). Gut tissues were then treated with 0.5 mg/ml 
collagenase D (Roche), 3 mg/ml dispase II (Roche), and 0.5 mg/ml DNase 
I (Roche) for 30 min in 37°C on a shaker (200 rpm). Lymphocytes were 
subsequently purified using 44/67% Percoll gradient (800 g at 20°C for 
20 min; Weigmann et al., 2007). Healthy human PBMCs were obtained from 
the Australian Red Cross, ethics approval 13-04VIC-07 (Australian Red 
Cross) and 1035100.1 (University of Melbourne). PBMCs were isolated using 
a histopaque-1077 (Sigma-Aldrich) density gradient centrifugation before 
staining for flow cytometric analysis.
Tetramers. Mouse and human MR1–5-OP-RU tetramers were generated 
by refolding MR1 monomers with 5-A-RU and methylglyoxal, as previ-
ously described (Corbett et al., 2014). Mouse and human MR1–Ac-6-FP 
tetramers were also generated as previously described (Eckle et al., 2014). 
C-terminal cysteine-tagged MR1–5-OP-RU was generated as described 
previously (Corbett et al., 2014) and then reduced with 5 mM DTT for 
20 min before buffer exchange into PBS using a PD-10 column (GE Healthcare) 
and biotinylated with Maleimide-PEG2 biotin (Thermo Fisher Scientific) 
with a 30:1 molar ratio of biotin/protein at 4°C for 16 h in the dark. Bio-
tinylated MR1 was subjected to S200 10/300 GL (GE Healthcare) chroma-
tography to remove excess biotin. Biotinylated MR1–5-OP-RU monomers 
were tetramerized with streptavidin conjugated to either PE (SA-PE) or 
Brilliant Violet 421 (SA-BV; BD). Soluble mouse CD1d/2m was prepared 
as previously described (Pellicci et al., 2009). The -GalCer analogue PBS-44 
with a C24:1 acyl chain, a gift of P. Savage (Brigham Young University, Provo, 
UT), was incubated with purified CD1d-biotin at a 6:1 (lipid/protein) molar 
ratio at 37°C overnight. SA-PE (BD) or SA-BV (BioLegend) was added 
sequentially (1/8 the required volume), including a series of 10-min incu-
bations at 4°C.
Single cell TCR sequence determination. cDNA from sorted MR1–5-
OP-RU tetramer+ TCR-+ intermediate cells was generated by the addition 
of 2 µl per well of buffer containing SuperScript VILO (Invitrogen) and 0.1% 
Triton X-100 (Sigma-Aldrich) and incubated according to the manufactur-
er’s instructions. Transcripts encoding V and V were amplified by two 
rounds of nested PCR as previously described (Dash et al., 2011). PCR prod-
ucts were separated on a 1.5% agarose gel and sequenced (Applied Genetics 
Diagnostics, University of Melbourne).
CTV labeling and proliferation assay. Splenocytes from WT C57BL/6 
mice were labeled with CTV and incubated for 10 min at 37°C. Labeled 
cells were cultured for 3 d in the presence of graded doses of 5-OP-RU Ag 
or Ac-6-FP or no stimulation. For proliferative analysis, cells were harvested 
after 72 h and stained with anti–TCR- and MR1–5-OP-RU tetramer. 
Generational divisions of proliferating MAIT cells were determined with 
FlowJo software (Tree Star).
Cell surface staining. In vitro stimulated cells were stained with MR1-Ag 
tetramer, or -GalCer (PBS-44)–loaded CD1d tetramer conjugated to PE, 
7-aminoactinomycin D (Sigma-Aldrich), anti–CD45R-allophycocyanin 
(APC)-Cy7 (BD) and anti–TCR-–APC (BD). For V analysis, anti–TCR- 
was excluded from the antibody cocktail, instead, and a secondary stain was 
performed using anti–V-FITC (BD). Proliferative responses were assessed 
using LSR II or LSR Fortessa flow cytometers (BD) and FlowJo software. 
Tetramer staining experiments were performed using an LSR Fortessa (BD) 
equipped with a yellow laser.
Intracellular cytokine staining. Lymphocytes were cultured in cell culture 
medium containing 10 ng/ml PMA (Sigma-Aldrich), 1 µg/ml ionomycin 
(Sigma-Aldrich), and 2 μM monensin (GolgiStop; BD) for 4 h. Cells were 
then washed and labeled with cell surface antibodies before fixation and 
permeabilization using the Cytofix/Cytoperm staining kit (BD) as per the 
manufacturer’s instructions. Cells were subsequently washed and stained for 
intracellular anti–IFN- and anti–IL-17A (BD) for flow cytometric analysis.
depleted in PLZF mutant mice highlights the important role 
that PLZF plays in the generation of these cells. Interestingly, 
the fact that the few remaining PLZF-independent MAIT cells 
still expressed the invariant TRAV1-TRAJ33 TCR- chain, 
yet were enriched for CD4+CD8, suggested that this subset 
of MAIT cells either represents a developmentally distinct 
sublineage or a precursor that requires PLZF for further matu-
ration. Very little is known about CD4+ MAIT cells, but their 
overrepresentation in lymph nodes and in PLZF mutant mice 
suggests that they may play a distinct role in the immune sys-
tem, and future studies should compare the development 
and function of these cells with double-negative and CD8+ 
MAIT cells.
Collectively, this study provides a comprehensive analy-
sis of MAIT cells in WT mice using MR1-Ag tetramers. We 
have revealed previously unrecognized subsets of MAIT cells 
in mice, including a major population of RORt+ IL-17A– 
producing MAIT cells and a minor population of T-bet+ 
IFN-–producing MAIT cells. Furthermore, we have shown 
that mouse MAIT cells have a memory phenotype, they ex-
press the transcription factor PLZF, and have a strong depen-
dence on this factor for their normal development. This study 
therefore demonstrates that mouse MAIT cells are far more 
aligned with human MAIT cells than previously recognized 
and thus provides an important foundation for future studies 
of MAIT cell development and function in mouse models 
of health and disease.
MATERIALS AND METHODS
Mice. C57BL/6 (B6), MR1/, and BALB/c mice were bred in house at the 
Department of Microbiology and Immunology Animal House, University of 
Melbourne. V19 TCR transgenic C/ and MR1/ mice were back-
crossed at least 10 times to the B6 background and were a gift from S. Gilfillan 
(Washington University in St. Louis School of Medicine, St. Louis, MO). The 
Plzf/ mice were identified in an N-ethyl-N-nitrosourea (ENU) random 
mutagenesis screen because of their skeletal abnormality. The strain was initially 
generated on a mixed C57BL/6 and CBA.H background and backcrossed for 
12 generations to C57BL/6. The phenotype was linked to an interval between 
SNP accession numbers rs3667699 and rs13480241 on chromosome 9. PLZF 
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